Mark Fawcett - Feb 25, 2021 Form 4 Insider Report for Clinigence Holdings, Inc. (NUTX)

Role
Director
Signature
Mark Fawcett
Stock symbol
NUTX
Transactions as of
Feb 25, 2021
Transactions value $
$571,255
Form type
4
Date filed
12/21/2021, 12:26 PM
Next filing
Jan 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUTX Common Stock Other $547K +268K +2982.03% $2.04* 277K Jan 28, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUTX Director Stock Option (right to buy) Purchase +85.1K 85.1K Aug 5, 2020 Common Stock 85.1K Direct F2
transaction NUTX Warrants to Puchase common stock Purchase $24K +3.6K $6.67* 3.6K Mar 21, 2019 Common Stock 3.6K $6.67 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as per Merger Transaction exchange
F2 10,120 shares at $5.56/share exercise date 8/5/2020 expiration date 8/5/2029 45,000 shares at $1.50/share exercise date 1/27/2020 expiration date 1/27/2027 30,000 shares at $1.50/share exercise date 5/11/2020 expiration date 12/31/2024